Written and reviewed by Dr. Amina Khalid, MRCOG · Last reviewed 28 October 2026 · Based on NICE and RCOG guidance current in October 2026
MRCOG Part 2 rarely catches you out on what you’ve never heard of. It catches you on what you nearly know: the aspirin dose you remember as a single number, the twin gestation you apply to every twin pregnancy, the magnesium clock you start in the wrong place.
The answers in Part 2 SBAs follow UK guidance, mainly NICE and RCOG Green-top Guidelines. The wrong options are usually written to match the most common half-remembered version of that guidance. Below are 10 of those traps. For each one you’ll find what the UK guideline says, why candidates pick the wrong answer, and an exam-style question to test yourself.
Key takeaways
- Aspirin: 75–150 mg daily from 12 weeks until birth, for one high-risk factor or more than one moderate risk factor (NICE NG133).
- Blood pressure: target 135/85 mmHg or less; labetalol first, then nifedipine, then methyldopa (NICE NG133).
- Magnesium sulfate: 4 g IV loading dose, then 1 g/hour for 24 hours, restarting the 24 hours after any further fit (NICE NG133).
- Timing of birth: pre-eclampsia from 37+0 within 24–48 hours; uncomplicated DCDA twins from 37+0, MCDA from 36+0, MCMA at 32+0 to 33+6 (NICE NG133, NG137).
- Breech: offer ECV from 36 weeks if nulliparous, 37 weeks if multiparous (RCOG GTG 20a).
- PPROM: erythromycin 250 mg four times a day for up to 10 days; never co-amoxiclav (NICE NG25).
- Ectopic: hCG 1,500–5,000 IU/L means a choice of methotrexate or surgery; after methotrexate, check hCG on days 4 and 7, then weekly until negative (NICE NG126).
Prefer a printable copy? Download the free MRCOG Part 2: 10 Exam Traps PDF, with all 10 traps and practice questions on one page each. Download the free PDF
The 10 traps at a glance
- Aspirin: dose and timing
- Aspirin: who gets it
- Blood pressure target and first-line drug
- Magnesium sulfate regimen
- Pre-eclampsia: when to deliver
- Uncomplicated twins: timing of birth
- External cephalic version
- PPROM antibiotics
- Ectopic pregnancy: methotrexate or surgery?
- Follow-up after methotrexate
Trap 1: What aspirin dose does NICE recommend for pre-eclampsia, and for how long?
Source: NICE NG133, Hypertension in pregnancy
The UK answer: NICE NG133 recommends aspirin 75–150 mg once daily from 12 weeks of pregnancy until the birth of the baby for women at high risk of pre-eclampsia, or with more than one moderate risk factor.
Why candidates get it wrong
- NICE gives a dose range, not a single fixed dose. Any option inside 75–150 mg is in line with NICE.
- Aspirin continues until birth. An option that stops it at 36 weeks, or any set gestation, doesn’t match NICE.
- Aspirin is prophylaxis started from 12 weeks. It isn’t a treatment once pre-eclampsia has developed.
Risk is assessed at the booking appointment. Who qualifies is a separate trap, covered next.
A 34-year-old woman books at 10 weeks. Her last pregnancy was complicated by pre-eclampsia. She is otherwise well. What is the most appropriate advice?
Show answerHide answer
Answer: A. Hypertensive disease in a previous pregnancy is a high-risk factor, and one high-risk factor is enough. NICE advises 75–150 mg from 12 weeks until birth.
Trap 2: Who should take aspirin to prevent pre-eclampsia?
Source: NICE NG133
The UK answer: NICE NG133 advises aspirin to prevent pre-eclampsia for any woman with one high-risk factor, or with more than one moderate risk factor.
| High risk (one is enough) | Moderate risk (need more than one) |
|---|---|
| Hypertensive disease in a previous pregnancy | Nulliparity |
| Chronic kidney disease | Age 40 or older |
| Autoimmune disease such as SLE or antiphospholipid syndrome | Pregnancy interval of more than 10 years |
| Type 1 or type 2 diabetes | BMI 35 kg/m² or more at first visit |
| Chronic hypertension | Family history of pre-eclampsia |
| Multi-fetal pregnancy |
Why candidates get it wrong
- One moderate factor on its own, such as nulliparity, is not an indication.
- Multiple pregnancy is a moderate risk factor, not a high-risk one.
- The diabetes on the high-risk list is pre-existing type 1 or type 2. Gestational diabetes isn’t on either list.
Which of these women should be advised to take aspirin to reduce the risk of pre-eclampsia?
Show answerHide answer
Answer: B. She has two moderate risk factors: nulliparity and age 40 or older. A and D have only one moderate factor each; C and E have none on NICE’s lists.
Trap 3: What is the blood pressure target and first-line drug in pre-eclampsia?
Source: NICE NG133
The UK answer: in pre-eclampsia, NICE NG133 sets a target blood pressure of 135/85 mmHg or less on treatment. Labetalol is first-line; nifedipine is used if labetalol isn’t suitable, and methyldopa if neither is suitable.
Why candidates get it wrong
- The target is 135/85 mmHg, not a “normal” non-pregnant blood pressure.
- In NICE, labetalol comes first. Nifedipine is the alternative when labetalol isn’t suitable, for example in asthma.
Also remember: severe hypertension in NG133 means systolic over 160 mmHg or diastolic over 110 mmHg.
A woman at 32 weeks has pre-eclampsia with a blood pressure of 152/102 mmHg. She has no history of asthma. Which antihypertensive should be offered first?
Show answerHide answer
Answer: A. NICE recommends labetalol first-line in pre-eclampsia, nifedipine if labetalol isn’t suitable, and methyldopa if neither is. ACE inhibitors such as enalapril aren’t used in pregnancy.
Trap 4: What is the magnesium sulfate regimen for severe pre-eclampsia and eclampsia?
Source: NICE NG133
The UK answer: NICE NG133 recommends magnesium sulfate as a 4 g IV loading dose over 5–15 minutes, then an infusion of 1 g/hour for 24 hours. If the woman has an eclamptic fit, the infusion continues for 24 hours after the last fit.
Why candidates get it wrong
- Counting 24 hours from the start of the infusion even after a further fit. After a fit, the clock restarts from the last fit.
- Mixing up the loading dose (4 g) and the hourly maintenance dose (1 g).
Also remember: the MHRA warns that magnesium sulfate given in pregnancy for longer than 5–7 days has been linked to skeletal adverse effects in the baby.
A woman with severe pre-eclampsia is on a magnesium sulfate infusion. Six hours after it starts, she has an eclamptic fit. How long should the infusion continue?
Show answerHide answer
Answer: B. NICE says that if a woman has had an eclamptic fit, the infusion continues for 24 hours after the last fit.
Trap 5: When should a woman with pre-eclampsia give birth?
Source: NICE NG133
The UK answer: NICE NG133 recommends continued surveillance in pre-eclampsia before 37 weeks unless there’s an indication for planned early birth, and initiating birth within 24–48 hours from 37+0 weeks.
| Gestation | NICE recommendation |
|---|---|
| Before 34+0 | Continue surveillance unless there’s an indication for planned early birth |
| 34+0 to 36+6 | Continue surveillance unless there are indications, taking the woman’s and baby’s condition into account |
| From 37+0 | Initiate birth within 24–48 hours |
Why candidates get it wrong
- Delivering a stable woman simply because she has reached 34 weeks. NICE’s default before 37 weeks is surveillance unless there’s an indication.
- Waiting longer than 48 hours at term. From 37 weeks, NICE says initiate birth within 24–48 hours.
If planned birth is needed before 34 weeks, offer magnesium sulfate and antenatal corticosteroids in line with NICE NG25 (preterm labour and birth).
A woman at 37+2 weeks has pre-eclampsia. Her blood pressure is controlled, her blood tests are normal and the CTG is normal. What is the most appropriate plan?
Show answerHide answer
Answer: B. From 37 weeks, NICE recommends initiating birth within 24–48 hours in pre-eclampsia, even when she is stable.
Trap 6: When should uncomplicated DCDA, MCDA and MCMA twins be delivered?
Source: NICE NG137, Twin and triplet pregnancy
The UK answer: NICE NG137 recommends planned birth for uncomplicated twins from 37+0 weeks for DCDA, from 36+0 weeks for MCDA, and between 32+0 and 33+6 weeks for MCMA twins.
| Chorionicity | Offer planned birth | Continuing beyond this increases the risk of fetal death |
|---|---|---|
| DCDA | From 37+0 weeks | 37+6 |
| MCDA | From 36+0 weeks | 36+6 |
| MCMA | Between 32+0 and 33+6 weeks | 33+6 |
Why candidates get it wrong
- Using one gestation for every twin pregnancy. It depends on chorionicity and amnionicity.
- Waiting too long. Continuing beyond the gestations above increases the risk of fetal death.
Also remember: MCMA twins born at 32+0 to 33+6 usually need neonatal unit admission and have more respiratory problems. For trichorionic or dichorionic triamniotic triplets, continuing beyond 35+6 weeks increases the risk of fetal death.
A woman with an uncomplicated monochorionic diamniotic twin pregnancy is seen at 32 weeks. When should planned birth be offered?
Show answerHide answer
Answer: B. For uncomplicated MCDA twins, NICE says planned birth from 36+0 weeks. 37+0 is for DCDA, and 32+0 to 33+6 is for MCMA.
Trap 7: When should external cephalic version (ECV) be offered?
The UK answer: RCOG Green-top Guideline 20a advises offering external cephalic version for breech presentation from 36 weeks in nulliparous women and from 37 weeks in multiparous women.
Why candidates get it wrong
- Using one gestation for everyone. The timing depends on parity.
- Going straight to planned caesarean section for an uncomplicated breech without offering ECV.
Also remember: RhD-negative women need anti-D after ECV, because it’s a potentially sensitising event.
A multiparous woman is found to have a breech presentation at 36+0 weeks. The pregnancy is otherwise uncomplicated. What is the most appropriate plan?
Show answerHide answer
Answer: B. RCOG advises offering ECV from 37 weeks in multiparous women (36 weeks in nulliparous women).
Trap 8: Which antibiotic is recommended for PPROM?
Source: NICE NG25, Preterm labour and birth
The UK answer: for preterm prelabour rupture of membranes (PPROM), NICE NG25 recommends oral erythromycin 250 mg four times a day for a maximum of 10 days, or until established labour if sooner. If erythromycin isn’t tolerated or is contraindicated, consider an oral penicillin. Co-amoxiclav should not be offered.
Why candidates get it wrong
- Choosing co-amoxiclav for “broader cover”. NICE says do not offer co-amoxiclav as prophylaxis in PPROM; it has been linked to neonatal necrotising enterocolitis.
- Continuing antibiotics indefinitely. The maximum is 10 days.
Also remember: antenatal corticosteroids are offered between 24+0 and 33+6 weeks when preterm birth is expected (NICE quality standard QS135).
A woman at 30 weeks has confirmed preterm prelabour rupture of membranes. She has no allergies. Which antibiotic regimen is recommended?
Show answerHide answer
Answer: A. NICE recommends erythromycin for a maximum of 10 days or until established labour. Co-amoxiclav isn’t offered because of the link with neonatal necrotising enterocolitis.
Trap 9: Ectopic pregnancy: when is methotrexate or surgery offered?
Source: NICE NG126, Ectopic pregnancy and miscarriage
| Methotrexate first-line (all of these) | Surgery first-line (any of these) |
|---|---|
| No significant pain | Significant pain |
| Unruptured mass under 35 mm, no visible heartbeat | Mass 35 mm or larger |
| Serum hCG under 1,500 IU/L | Visible fetal heartbeat |
| No intrauterine pregnancy on ultrasound | Serum hCG 5,000 IU/L or more |
| Able to return for follow-up | Unable to return for follow-up |
The UK answer: for a tubal ectopic pregnancy with serum hCG between 1,500 and 5,000 IU/L, NICE NG126 says offer a choice of methotrexate or surgery, as long as the other methotrexate criteria are met. Below 1,500 IU/L methotrexate is first-line; at 5,000 IU/L or more, surgery is.
Why candidates get it wrong
- Treating 1,500 IU/L as a hard cut-off for surgery. Between 1,500 and 5,000 IU/L, it’s the woman’s choice.
- Forgetting the non-hCG criteria: a visible heartbeat or significant pain points to surgery whatever the hCG.
A woman has an unruptured tubal ectopic of 28 mm with no visible heartbeat. Her hCG is 2,800 IU/L, she has minimal pain and can attend follow-up. What should she be offered?
Show answerHide answer
Answer: C. With hCG between 1,500 and 5,000 IU/L and the other methotrexate criteria met, NICE says offer a choice of methotrexate or surgery.
Trap 10: What hCG follow-up is needed after methotrexate for ectopic pregnancy?
Source: NICE NG126
The UK answer: after methotrexate for ectopic pregnancy, NICE NG126 recommends measuring serum hCG on day 4 and day 7, then once a week until it is negative.
Why candidates get it wrong
- Mixing it up with the 48-hour hCG measurements used to assess a pregnancy of unknown location.
- Stopping follow-up once hCG starts to fall. NICE says continue weekly until negative.
Also remember: if hCG plateaus or rises, reassess the woman for further treatment.
A woman has been treated with methotrexate for a tubal ectopic pregnancy. What follow-up is recommended?
Show answerHide answer
Answer: B. NICE recommends hCG on days 4 and 7, then weekly until negative, reassessing if levels plateau or rise.
Quick-reference summary
| Trap | The UK answer | Source |
|---|---|---|
| 1. Aspirin dose and timing | 75–150 mg daily from 12 weeks until birth | NICE NG133 |
| 2. Aspirin eligibility | 1 high-risk factor, or more than 1 moderate | NICE NG133 |
| 3. BP target and drug | 135/85 mmHg; labetalol, then nifedipine, then methyldopa | NICE NG133 |
| 4. Magnesium sulfate | 4 g IV over 5–15 min, then 1 g/hour for 24 hours (24 hours after the last fit) | NICE NG133 |
| 5. Pre-eclampsia birth timing | Surveillance before 37 weeks unless indicated; from 37+0 initiate birth within 24–48 hours | NICE NG133 |
| 6. Uncomplicated twins | DCDA from 37+0; MCDA from 36+0; MCMA 32+0 to 33+6 | NICE NG137 |
| 7. ECV | From 36 weeks nulliparous, 37 weeks multiparous | RCOG GTG 20a |
| 8. PPROM antibiotics | Erythromycin 250 mg QDS, max 10 days; no co-amoxiclav | NICE NG25 |
| 9. Ectopic treatment | hCG 1,500–5,000 IU/L: choice of methotrexate or surgery | NICE NG126 |
| 10. After methotrexate | hCG day 4 and day 7, then weekly until negative | NICE NG126 |
Frequently asked questions
What aspirin dose does NICE recommend to prevent pre-eclampsia?
NICE NG133 recommends 75–150 mg of aspirin once daily from 12 weeks of pregnancy until the baby is born. It is offered to women with one high-risk factor, such as hypertensive disease in a previous pregnancy, or more than one moderate risk factor, such as nulliparity plus age 40 or older.
When should uncomplicated MCDA twins be delivered?
NICE NG137 recommends offering planned birth for uncomplicated monochorionic diamniotic (MCDA) twins from 36+0 weeks, because continuing beyond 36+6 weeks increases the risk of fetal death. Uncomplicated DCDA twins are offered birth from 37+0 weeks, and MCMA twins between 32+0 and 33+6 weeks.
When is external cephalic version (ECV) offered for breech?
RCOG Green-top Guideline 20a advises offering ECV from 36 weeks in nulliparous women and from 37 weeks in multiparous women with an uncomplicated breech presentation. RhD-negative women should receive anti-D after ECV.
What antibiotic is given for PPROM in the UK?
NICE NG25 recommends oral erythromycin 250 mg four times a day for up to 10 days, or until the woman is in established labour if sooner. An oral penicillin is an alternative if erythromycin isn’t suitable. Co-amoxiclav is not offered because it has been linked to neonatal necrotising enterocolitis.
When is methotrexate used for ectopic pregnancy?
NICE NG126 makes methotrexate first-line when a woman has no significant pain, an unruptured mass under 35 mm with no visible heartbeat, serum hCG under 1,500 IU/L, no intrauterine pregnancy, and can return for follow-up. Between 1,500 and 5,000 IU/L she is offered a choice of methotrexate or surgery.
Are MRCOG Part 2 answers based on NICE or RCOG guidelines?
MRCOG Part 2 single best answer questions are written to UK practice, so the expected answer follows current NICE guidance and RCOG Green-top Guidelines. Where both cover the same topic, learn both and note where they differ.
How should I use these traps in my MRCOG Part 2 revision?
After each topic, write down the guideline you’d quote and the one detail most likely to be changed in a wrong option: a gestation, a dose, a cut-off or a duration. Then practise exam-style questions on that topic until you pick the right option without hesitating.
Where can I practise more MRCOG Part 2 questions?
MRCOG Prep has 150+ free MRCOG Part 2 questions with full explanations. Start your free trial.
Practise it the way it’s examined
Knowing the guideline isn’t the same as picking the right option under time pressure. MRCOG Prep’s Part 2 question bank is written in exam style, with full explanations that tell you why each wrong option is wrong.
TRY 150+ MRCOG PART 2 QUESTIONS FREE
This article is an exam revision summary based on NICE NG133, NG137, NG126, NG25 and QS135, and RCOG Green-top Guideline 20a. It is not clinical guidance; always follow the full guidelines and your local protocols.